VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
2662
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
479
Interactions with Platform & by Email
PARTICIPANTS
82
Unique # Participated
VALIDATIONS
37
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEPTEMBER 2020
TABLES
108
PAGES
182
EDITION
9
PRICE
USD $5450
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Dermatophytic Onychomycosis Treatment Market?
Amid the COVID-19 crisis, the global market for Dermatophytic Onychomycosis Treatment estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$6.5 Billion by 2027, growing at a CAGR of 11.8% over the analysis period 2020-2027. Systemic Therapy, one of the segments analyzed in the report, is projected to record a 10.7% CAGR and reach US$2.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Topical Therapy segment is readjusted to a revised 12.6% CAGR for the next 7-year period.
The Dermatophytic Onychomycosis Treatment market in the U.S. is estimated at US$874.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 10.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.
In the global Device-based Therapy segment, USA, Canada, Japan, China and Europe will drive the 11% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$89.8 Million in the year 2020 will reach a projected size of US$186.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$771 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Allergan PLC; Galderma SA; GlaxoSmithKline PLC; Johnson & Johnson; Moberg Pharma AB; NovaBiotics Ltd; Novartis AG; Pfizer, Inc.; Sanofi SA; Valeant Pharmaceuticals International, Inc.
» End-Use (Hospitals, Dermatology Clinics, Retail Pharmacies, Other End-Uses) » Segment (Systemic Therapy, Topical Therapy, Device-based Therapy)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Dermatophytic Onychomycosis Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Dermatophytic Onychomycosis Treatment Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Dermatophytic Onychomycosis Treatment Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Systemic Therapy (Segment) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Systemic Therapy (Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Systemic Therapy (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Topical Therapy (Segment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Topical Therapy (Segment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Topical Therapy (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Device-based Therapy (Segment) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Device-based Therapy (Segment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Device-based Therapy (Segment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Hospitals (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Hospitals (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Hospitals (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Dermatology Clinics (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Dermatology Clinics (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Dermatology Clinics (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Retail Pharmacies (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Retail Pharmacies (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Retail Pharmacies (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Other End-Uses (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Other End-Uses (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Other End-Uses (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Dermatophytic Onychomycosis Treatment Market Share (in %) by Company: 2019 & 2025 |
| United States Dermatophytic Onychomycosis Treatment Market Estimates and Projections in US$ Million by Segment: 2018 to 2025 |
| Dermatophytic Onychomycosis Treatment Market in the United States by Segment: A Historic Review in US$ Million for 2009-2017 |
| United States Dermatophytic Onychomycosis Treatment Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| United States Dermatophytic Onychomycosis Treatment Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Dermatophytic Onychomycosis Treatment Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Dermatophytic Onychomycosis Treatment Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025 |
| Canadian Dermatophytic Onychomycosis Treatment Historic Market Review by Segment in US$ Million: 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025 |
| Canadian Dermatophytic Onychomycosis Treatment Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Dermatophytic Onychomycosis Treatment Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Canadian Dermatophytic Onychomycosis Treatment Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| JAPAN |
| Japanese Market for Dermatophytic Onychomycosis Treatment: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017 |
| Japanese Dermatophytic Onychomycosis Treatment Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Dermatophytic Onychomycosis Treatment in US$ Million by End-Use: 2018 to 2025 |
| Japanese Dermatophytic Onychomycosis Treatment Market in US$ Million by End-Use: 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Dermatophytic Onychomycosis Treatment Market Growth Prospects in US$ Million by Segment for the Period 2018-2025 |
| Dermatophytic Onychomycosis Treatment Historic Market Analysis in China in US$ Million by Segment: 2009-2017 |
| Chinese Dermatophytic Onychomycosis Treatment Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Dermatophytic Onychomycosis Treatment in US$ Million by End-Use: 2018 to 2025 |
| Dermatophytic Onychomycosis Treatment Market Review in China in US$ Million by End-Use: 2009-2017 |
| Chinese Dermatophytic Onychomycosis Treatment Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| EUROPE |
| Market Facts & Figures |
| European Dermatophytic Onychomycosis Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Dermatophytic Onychomycosis Treatment Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Dermatophytic Onychomycosis Treatment Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Dermatophytic Onychomycosis Treatment Market Estimates and Forecasts in US$ Million by Segment: 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017 |
| European Dermatophytic Onychomycosis Treatment Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| European Dermatophytic Onychomycosis Treatment Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| European Dermatophytic Onychomycosis Treatment Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| FRANCE |
| Dermatophytic Onychomycosis Treatment Market in France by Segment: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Dermatophytic Onychomycosis Treatment Historic Market Scenario in US$ Million by Segment: 2009-2017 |
| French Dermatophytic Onychomycosis Treatment Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| Dermatophytic Onychomycosis Treatment Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025 |
| French Dermatophytic Onychomycosis Treatment Historic Market Review in US$ Million by End-Use: 2009-2017 |
| French Dermatophytic Onychomycosis Treatment Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| GERMANY |
| Dermatophytic Onychomycosis Treatment Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| German Dermatophytic Onychomycosis Treatment Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| German Dermatophytic Onychomycosis Treatment Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| Dermatophytic Onychomycosis Treatment Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| German Dermatophytic Onychomycosis Treatment Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Dermatophytic Onychomycosis Treatment Market Growth Prospects in US$ Million by Segment for the Period 2018-2025 |
| Dermatophytic Onychomycosis Treatment Historic Market Analysis in Italy in US$ Million by Segment: 2009-2017 |
| Italian Dermatophytic Onychomycosis Treatment Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Dermatophytic Onychomycosis Treatment in US$ Million by End-Use: 2018 to 2025 |
| Dermatophytic Onychomycosis Treatment Market Review in Italy in US$ Million by End-Use: 2009-2017 |
| Italian Dermatophytic Onychomycosis Treatment Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Dermatophytic Onychomycosis Treatment: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017 |
| United Kingdom Dermatophytic Onychomycosis Treatment Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Dermatophytic Onychomycosis Treatment in US$ Million by End-Use: 2018 to 2025 |
| United Kingdom Dermatophytic Onychomycosis Treatment Market in US$ Million by End-Use: 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Dermatophytic Onychomycosis Treatment Market Estimates and Forecasts in US$ Million by Segment: 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017 |
| Rest of Europe Dermatophytic Onychomycosis Treatment Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| Rest of Europe Dermatophytic Onychomycosis Treatment Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Dermatophytic Onychomycosis Treatment Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| Rest of Europe Dermatophytic Onychomycosis Treatment Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Dermatophytic Onychomycosis Treatment Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Dermatophytic Onychomycosis Treatment Historic Market Scenario in US$ Million by Segment: 2009-2017 |
| Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| Dermatophytic Onychomycosis Treatment Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025 |
| Asia-Pacific Dermatophytic Onychomycosis Treatment Historic Market Review in US$ Million by End-Use: 2009-2017 |
| Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| REST OF WORLD |
| Rest of World Dermatophytic Onychomycosis Treatment Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025 |
| Rest of World Dermatophytic Onychomycosis Treatment Historic Market Review by Segment in US$ Million: 2009-2017 |
| Dermatophytic Onychomycosis Treatment Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025 |
| Rest of World Dermatophytic Onychomycosis Treatment Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Dermatophytic Onychomycosis Treatment Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Rest of World Dermatophytic Onychomycosis Treatment Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 5 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com